Why Tirzepatide Continues to Outperform in Clinical Trials
New head-to-head trial data shows why tirzepatide keeps outpacing semaglutide on weight loss and blood sugar control.
Read MoreNew head-to-head trial data shows why tirzepatide keeps outpacing semaglutide on weight loss and blood sugar control.
Read More
Food cravings aren't a failure of willpower — they're driven by hormones, brain chemistry, stress, sleep, and your...
Read More
Both routes work, but oral and sublingual GLP-1 medications offer real advantages in convenience, dosing flexibility, and privacy...
Read More
Metabolic Health · GLP-1 Medications Tirzepatide vs. Semaglutide: Why the Dual-Action Approach Wins When it comes to managing...
Read More
Max Lugavre testified during a recent senate hearing to end the corporate capture of our regulatory bodies and academic institutions by the food and pharmaceutical industries....
Read More
The Hidden Value of Our Contagion Kit Round 2 of insanity is about to be unleashed on the American people. California historically leads the nation in...
Read More
Each membership tier has been carefully designed to meet different needs. If you have been undecided about which wellness membership is the best fit for you,...
Read More
When on the go, it can be almost impossible to get all the nutrients you need. Planning, shopping, and preparing meals take time. A lot of...
Read More
The power of digestive enzymes How does our body turn that delicious meal we just ate into the building blocks needed to keep our body healthy...
Read More
In the aftermath of Helene, many are finding themselves without water, food, or proper sanitation. Wells have become contaminated with septic tanks overflowing after the unprecedented...
Read More
List price of Wegovy is over 16,000 dollars annually In the quest to achieve ideal weight, many are turning to pharmaceuticals designed for weight loss. These...
Read More
But they all are part of the gain of function research The Chief Science Officer of The Wellness Company Dr. Peter McCullough has been reporting on...
Read More